| Entry |
|
|---|
| Name |
Fananserin (USAN/INN) |
|---|
| Formula |
C23H24FN3O2S
|
|---|
| Exact mass |
425.1573
|
|---|
| Mol weight |
425.519
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01476 Dopamine D4-receptor antagonist
|
|---|
| Efficacy |
Antipsychotic |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01478 Dopamine antagonist
DG01476 Dopamine D4-receptor antagonist
D02656 Fananserin
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD4
D02656 Fananserin (USAN/INN)
Serotonin
HTR2A
D02656 Fananserin (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 30
1 C8x C 24.4238 -16.4696
2 C8y C 24.4238 -17.8604
3 C8x C 25.6060 -18.5559
4 C8x C 26.8577 -17.8604
5 C8y C 26.8577 -16.4696
6 C8x C 25.6060 -15.7742
7 X F 23.2416 -18.5559
8 N1y N 28.0400 -15.7742
9 C1x C 29.2222 -16.4696
10 C1x C 30.4739 -15.7742
11 N1y N 30.4739 -14.3834
12 C1x C 29.2916 -13.6879
13 C1x C 28.0400 -14.3834
14 C1b C 31.6561 -13.6879
15 C1b C 32.9078 -14.3834
16 C1b C 34.0900 -13.6879
17 N1y N 35.2722 -14.3834
18 C8x C 39.4447 -13.8966
19 C8x C 37.3585 -17.5128
20 C8x C 38.7494 -17.5128
21 C8x C 39.4447 -16.3305
22 C8y C 38.7494 -15.0787
23 C8y C 37.3585 -15.0787
24 C8y C 36.6631 -16.3305
25 C8x C 38.7494 -12.7144
26 C8x C 37.3585 -12.7144
27 C8y C 36.6631 -13.8966
28 S2x S 35.2722 -15.8438
29 O3c O 34.9100 -17.1956
30 O3c O 33.9205 -15.4815
BOND 35
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 2 7 1
8 5 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 8 13 1
15 11 14 1
16 14 15 1
17 15 16 1
18 16 17 1
19 19 20 1
20 20 21 2
21 21 22 1
22 22 23 2
23 23 24 1
24 19 24 2
25 22 18 1
26 18 25 2
27 25 26 1
28 26 27 2
29 23 27 1
30 24 28 1
31 27 17 1
32 28 17 1
33 17 28 1
34 28 29 2
35 28 30 2
|
|---|
